{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:20:50Z","timestamp":1791829250199,"version":"4.3.4"},"reference-count":85,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T00:00:00Z","timestamp":1710633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20236"],"award-info":[{"award-number":["U23A20236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["ZD2023C006"],"award-info":[{"award-number":["ZD2023C006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["LH2023C084"],"award-info":[{"award-number":["LH2023C084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["U23A20236"],"award-info":[{"award-number":["U23A20236"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["ZD2023C006"],"award-info":[{"award-number":["ZD2023C006"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["LH2023C084"],"award-info":[{"award-number":["LH2023C084"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Coronaviruses in general are a zoonotic pathogen with significant cross-species transmission. They are widely distributed in nature and have recently become a major threat to global public health. Vaccines are the preferred strategy for the prevention of coronaviruses. However, the rapid rate of virus mutation, large number of prevalent strains, and lag in vaccine development contribute to the continuing frequent occurrence of coronavirus diseases. There is an urgent need for new antiviral strategies to address coronavirus infections effectively. Antiviral drugs are important in the prevention and control of viral diseases. Members of the genus coronavirus are highly similar in life-cycle processes such as viral invasion and replication. These, together with the high degree of similarity in the protein sequences and structures of viruses in the same genus, provide common targets for antiviral drug screening of coronaviruses and have led to important advances in recent years. In this review, we summarize the pathogenic mechanisms of coronavirus, common drugs targeting coronavirus entry into host cells, and common drug targets against coronaviruses based on biosynthesis and on viral assembly and release. We also describe the common targets of antiviral drugs against coronaviruses and the progress of antiviral drug research. Our aim is to provide a theoretical basis for the development of antiviral drugs and to accelerate the development and utilization of commonly used antiviral drugs in China.<\/jats:p>","DOI":"10.3390\/microorganisms12030600","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T06:58:39Z","timestamp":1710745119000},"page":"600","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Mini-Review on the Common Antiviral Drug Targets of Coronavirus"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-7924","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"first","affiliation":[{"name":"College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, No. 5 Xinfeng Road, Daqing 163319, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Zhu","sequence":"additional","affiliation":[{"name":"College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, No. 5 Xinfeng Road, Daqing 163319, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Xing","sequence":"additional","affiliation":[{"name":"College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, No. 5 Xinfeng Road, Daqing 163319, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, No. 5 Xinfeng Road, Daqing 163319, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2000028","DOI":"10.1002\/minf.202000028","article-title":"Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3\u2005Billion Compounds","volume":"39","author":"Ton","year":"2020","journal-title":"Mol. Inform."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/vop.12375","article-title":"A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1","volume":"19","author":"Thomasy","year":"2016","journal-title":"Vet. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/acs.jproteome.0c00526","article-title":"Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication","volume":"20","author":"Zhang","year":"2021","journal-title":"J. Proteome Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41421-020-0169-8","article-title":"The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro","volume":"6","author":"Wang","year":"2020","journal-title":"Cell Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/acs.jmedchem.7b01732","article-title":"Discovery of Hydrocarbon-Stapled Short alpha-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: Implications for SARS-CoV-2","volume":"19","author":"Kratzel","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12910","DOI":"10.1074\/jbc.REV120.013930","article-title":"The molecular virology of coronaviruses","volume":"295","author":"Hartenian","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv. Virus Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: An overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/jmv.26234","article-title":"Emerging coronaviruses: Genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"106054","DOI":"10.1016\/j.ijantimicag.2020.106054","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies","volume":"56","author":"Sharma","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group","volume":"87","author":"Baker","year":"2013","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"199075","DOI":"10.1016\/j.virusres.2023.199075","article-title":"Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals","volume":"328","author":"Cui","year":"2023","journal-title":"Virus Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Silva, L.R., da Silva Santos-J\u00fanior, P.F., de Andrade Brand\u00e3o, J., Anderson, L., Bassi, \u00ca.J., Xavier de Ara\u00fajo-J\u00fanior, J., Cardoso, S.H., and da Silva-J\u00fanior, E.F. (2020). Druggable targets from coronaviruses for designing new antiviral drugs. Bioorg. Med. Chem., 28.","DOI":"10.1016\/j.bmc.2020.115745"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105512","DOI":"10.1016\/j.micpath.2022.105512","article-title":"Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2","volume":"168","author":"Routhu","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_20","first-page":"100794","article-title":"An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment","volume":"59","author":"Rosik","year":"2021","journal-title":"Drug Resist. Updates Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-022-00884-5","article-title":"Structural biology of SARS-CoV-2: Open the door for novel therapies","volume":"7","author":"Yan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"199078","DOI":"10.1016\/j.virusres.2023.199078","article-title":"Molecular mechanisms of human coronavirus NL63 infection and replication","volume":"327","author":"Castillo","year":"2023","journal-title":"Virus Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"198897","DOI":"10.1016\/j.virusres.2022.198897","article-title":"Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2","volume":"320","author":"Upadhyay","year":"2022","journal-title":"Virus Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pu, J., He, X., Xu, W., Wang, C., Lan, Q., Hua, C., Wang, K., Lu, L., and Jiang, S. (2022). The Analogs of Furanyl Methylidene Rhodanine Exhibit Broad-Spectrum Inhibitory and Inactivating Activities against Enveloped Viruses, including SARS-CoV-2 and Its Variants. Viruses, 14.","DOI":"10.3390\/v14030489"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105998","DOI":"10.1016\/j.ijantimicag.2020.105998","article-title":"Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein","volume":"56","author":"Vankadari","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Pendyala, B., Patras, A., and Dash, C. (2021). Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.645713"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Alaofi, A.L., Shahid, M., Raish, M., Ansari, M.A., Syed, R., and Kalam, M.A. (2022). Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro. Molecules, 27.","DOI":"10.3390\/molecules27217553"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s13238-022-00909-3","article-title":"Targeting papain-like protease for broad-spectrum coronavirus inhibition","volume":"13","author":"Yuan","year":"2022","journal-title":"Protein Cell"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lin, Y., Zang, R., Ma, Y., Wang, Z., Li, L., Ding, S., Zhang, R., Wei, Z., Yang, J., and Wang, X. (2021). Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212134"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Chen, H., Zou, M., Oerlemans, R., Shao, C., Ren, Y., Zhang, R., Huang, X., Li, G., and Cong, Y. (2021). Hypericin Inhibit Alpha-Coronavirus Replication by Targeting 3CL Protease. Viruses, 13.","DOI":"10.3390\/v13091825"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13567-020-00865-y","article-title":"Tomatidine inhibits porcine epidemic diarrhea virus replication by targeting 3CL protease","volume":"51","author":"Wang","year":"2020","journal-title":"Vet. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Su, M., Yin, B., Xing, X., Li, Z., Zhang, J., Feng, S., Li, L., Zhao, F., Yang, X., and Yu, S. (2023). Octyl gallate targeting the 3C-like protease exhibits highly efficient antiviral activity against swine enteric coronavirus PEDV. Vet. Microbiol., 281.","DOI":"10.1016\/j.vetmic.2023.109743"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108672","DOI":"10.1016\/j.jmgm.2023.108672","article-title":"Discovery of pyrimidoindol and benzylpyrrolyl inhibitors targeting SARS-CoV-2 main protease (M(pro)) through pharmacophore modelling, covalent docking, and biological evaluation","volume":"127","author":"Mahgoub","year":"2024","journal-title":"J. Mol. Graph. Model."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Runfeng","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e2203499","DOI":"10.1002\/advs.202203499","article-title":"Gossypol Broadly Inhibits Coronaviruses by Targeting RNA-Dependent RNA Polymerases","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/AAC.02994-14","article-title":"Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses","volume":"58","author":"Adedeji","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41594-020-00536-8","article-title":"Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers","volume":"27","author":"Mandala","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e0018721","DOI":"10.1128\/JVI.00187-21","article-title":"Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication","volume":"95","author":"Su","year":"2021","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41392-023-01472-x","article-title":"Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"199170","DOI":"10.1016\/j.virusres.2023.199170","article-title":"SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein","volume":"334","author":"Stincarelli","year":"2023","journal-title":"Virus Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"105360","DOI":"10.1016\/j.antiviral.2022.105360","article-title":"Conserved coronavirus proteins as targets of broad-spectrum antivirals","volume":"204","author":"Bobrowski","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","article-title":"Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity","volume":"65","author":"Shen","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/med.21783","article-title":"What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design","volume":"41","author":"Xiong","year":"2021","journal-title":"Med. Res. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E3900-3909","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acs.jpclett.0c00571","article-title":"Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Phys. Chem. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"113201","DOI":"10.1016\/j.ejmech.2021.113201","article-title":"RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic","volume":"213","author":"Tian","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_51","first-page":"100632","article-title":"An overview on medicinal plants used for combating coronavirus: Current potentials and challenges","volume":"13","author":"Hassan","year":"2023","journal-title":"J. Agric. Food Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.37201\/req\/028.2020","article-title":"Remdesivir, the antiviral hope against SARS-CoV-2","volume":"33","author":"Reina","year":"2020","journal-title":"Rev. Espa\u00f1ola Quimioter."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3906\/sag-2004-145","article-title":"Antiviral treatment of COVID-19","volume":"50","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s12250-021-00362-2","article-title":"Significant Inhibition of Porcine Epidemic Diarrhea Virus In Vitro by Remdesivir, Its Parent Nucleoside and \u03b2-D-N(4)-hydroxycytidine","volume":"36","author":"Xie","year":"2021","journal-title":"Virol. Sin."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e02237-02220","DOI":"10.1128\/AAC.02237-20","article-title":"Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent","volume":"65","author":"Xu","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2020.08.116","article-title":"RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19","volume":"538","author":"Jiang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ijmm.2020.4794","article-title":"Approaches towards fighting the COVID-19 pandemic (Review)","volume":"47","author":"Tsai","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmii.2020.03.034","article-title":"Treatment options for COVID-19: The reality and challenges","volume":"53","author":"Jean","year":"2020","journal-title":"J. Microbiol. Immunol. Infect. Wei Mian Yu Gan Ran Za Zhi"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/JCMA.0000000000000318","article-title":"Potential therapeutic agents against COVID-19: What we know so far","volume":"83","author":"Lu","year":"2020","journal-title":"J. Chin. Med. Assoc. JCMA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1039\/D3OB02039H","article-title":"Two short approaches to the COVID-19 drug \u03b2-D-N(4)-hydroxycytidine and its prodrug molnupiravir","volume":"22","author":"Persaud","year":"2024","journal-title":"Org. Biomol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.cell.2020.07.033","article-title":"Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1093\/nar\/gkz409","article-title":"Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis","volume":"47","author":"Jia","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/acsinfecdis.2c00165","article-title":"Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors","volume":"8","author":"Yazdi","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1042\/BCJ20210201","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase","volume":"478","author":"Zeng","year":"2021","journal-title":"Biochem. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"602162","DOI":"10.3389\/fchem.2020.602162","article-title":"Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins","volume":"8","author":"Squeglia","year":"2020","journal-title":"Front. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/nar\/gkad1194","article-title":"An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complex","volume":"52","author":"Shannon","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1021\/acs.jmedchem.2c02120","article-title":"Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase","volume":"66","author":"Singh","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Asthana, A., Corona, A., Shin, W.J., Kwak, M.J., Gaughan, C., Tramontano, E., Jung, J.U., Schobert, R., Jha, B.K., and Silverman, R.H. (2023). Analogs of the Catechol Derivative Dynasore Inhibit HIV-1 Ribonuclease H, SARS-CoV-2 nsp14 Exoribonuclease, and Virus Replication. Viruses, 15.","DOI":"10.3390\/v15071539"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Kottur, J., White, K.M., Rodriguez, M.L., Rechkoblit, O., Quintana-Feliciano, R., Nayar, A., Garc\u00eda-Sastre, A., and Aggarwal, A.K. (2023). Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011546"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-019-08728-7","article-title":"The structure of a prokaryotic viral envelope protein expands the landscape of membrane fusion proteins","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pro.4075","article-title":"Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors","volume":"30","author":"Cao","year":"2021","journal-title":"Protein Sci. A Publ. Protein Soc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1080\/07391102.2020.1774419","article-title":"A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem)","volume":"39","author":"Borkotoky","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e105938","DOI":"10.15252\/embj.2020105938","article-title":"Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design","volume":"39","author":"Peng","year":"2020","journal-title":"EMBO J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41467-021-21953-3","article-title":"The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA","volume":"12","author":"Cubuk","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17460441.2019.1581171","article-title":"Broad-spectrum coronavirus antiviral drug discovery","volume":"14","author":"Totura","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Geraghty, R.J., Aliota, M.T., and Bonnac, L.F. (2021). Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses, 13.","DOI":"10.3390\/v13040667"},{"key":"ref_78","first-page":"1128","article-title":"TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection","volume":"93","author":"Okamura","year":"2019","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Mazzon, M., Ortega-Prieto, A.M., Imrie, D., Luft, C., Hess, L., Czieso, S., Grove, J., Skelton, J.K., Farleigh, L., and Bugert, J.J. (2019). Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry. Viruses, 11.","DOI":"10.3390\/v11020176"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/1568026620666201207095117","article-title":"An Updated Review on SARS-CoV-2 Main Proteinase (M(Pro)): Protein Structure and Small-Molecule Inhibitors","volume":"21","author":"Sabbah","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cell.2021.02.013","article-title":"Antivirals with common targets against highly pathogenic viruses","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"105499","DOI":"10.1016\/j.antiviral.2022.105499","article-title":"Influenza antivirals and their role in pandemic preparedness","volume":"210","author":"Jones","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biochi.2020.09.018","article-title":"The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2","volume":"179","author":"Muralidar","year":"2020","journal-title":"Biochimie"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"199103","DOI":"10.1016\/j.virusres.2023.199103","article-title":"Role of heat shock protein 90 as an antiviral target for swine enteric coronaviruses","volume":"329","author":"Zhao","year":"2023","journal-title":"Virus Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"198915","DOI":"10.1016\/j.virusres.2022.198915","article-title":"Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening","volume":"321","author":"Hu","year":"2022","journal-title":"Virus Res."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/3\/600\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:14:55Z","timestamp":1760105695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/3\/600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,17]]},"references-count":85,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["microorganisms12030600"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12030600","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,17]]}}}